Tag: #Global Trends

Driven by the unprecedented success of its diabetes and weight-loss franchise, CEO David Ricks received a compensation package totaling $36.7... Read more

In a decisive briefing on March 5, a high-ranking official from the Food and Drug Administration (FDA) challenged recent claims... Read more

Novartis has unveiled its strategy to establish a radioligand therapy (RLT) manufacturing center in Denton, Texas. This facility represents the... Read more

Swiss pharmaceutical giant Roche is injecting 710 billion won (approximately $484 million) into South Korea’s biopharma sector. This investment aims... Read more

On March 4, 2026, Fujifilm Biotechnologies introduced ShunzymeX, a precision purification technology designed to streamline downstream processing for complex biologics.... Read more

In a last-minute breakthrough just days before a scheduled jury trial, Moderna has agreed to a settlement worth up to... Read more

On March 3, 2026, Teva Pharmaceuticals and Blackstone Life Sciences announced a $400 million strategic funding agreement to accelerate the... Read more

On March 4, 2026, Antengene Corporation and UCB entered into a global licensing agreement worth up to $1.18 billion to... Read more

Sanofi has entered into a significant $1.53 billion global licensing agreement with Sino Biopharmaceutical for rovadicitinib, a first-in-class dual JAK/ROCK... Read more